Bill Blonigan Sheppard Mullin Richter & Hampton LLP
Results 1 to 4 of 4
Establishing the weight of evidence after Sciele *
USA - August 13 2012
Patents are presumptively valid under 35 U.S.C. § 282 and can be proven invalid only by clear and convincing evidence.
Co-authors: Eric Gill.
Patents issued in error are presumed valid, but evidence weighs heavily against them *
USA - August 3 2012
Patents are presumptively valid under 35 U.S.C. § 282 and can be proven invalid only by clear and convincing evidence.
Co-authors: Eric Gill.
Supreme Court confirms that generic drug manufacturers can challenge brand-name use-code descriptions in patent litigation *
USA - July 16 2012
Congress designed the Hatch-Waxman Act (codified at 21 U.S.C. § 355(b), (j), (l) and 35 U.S.C. §§ 156, 271, and 282) to inspire medical innovation by giving medical-device and pharmaceutical patent owners a more fruitful patent term while providing follow-on manufacturers to more quickly market their products once medical patents expire.
Co-authors: Nagendra (Nick) Setty .
Courts to play greater role moderating enhanced damages for willful patent infringement *
USA - July 3 2012
In this medical-device patent-infringement action, an Arizona federal jury found that W.L. Gore willfully infringed Bard’s Prosthetic Vascular Graft patent.
Co-authors: Martin Bader.
Co-authors of Bill Blonigan
Other Sheppard Mullin Richter & Hampton LLP authors
- Adam McNeile,
- Amy L. McEvoy ,
- Bram Hanono,
- Daniel P. Bane,
- Danielle Levine ,
- David A. Niemeyer ,
- David S. Gallacher,
- David Sands,
- Franklin C. Turner,
- Gregg A. Fisch ,
- Jennifer G. Redmond,
- John M. Landry ,
- John Stigi,
- John W. Chierichella,
- Mark E. McGrath ,
- Robert Rose,
- Robin A. Achen ,
- Thomas D. Nevins,
- Thomas R. Kaufman ,
- Valentina Shenderovich
